Thursday, 8 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Corona Remedies Ltd

NSE: CORONA · BSE: 544644 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹2,041.10
Market cap: ₹12,483 Cr
Revenue (annual): ₹1,403 Cr
Net profit (annual): ₹185.1 Cr
P/E (TTM): 62.7×Sector 47.3×
Promoter holding: 69.00%+0.00% QoQ
FII holding: 3.63%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Financial Results 3 Board Meeting Date 3 Results Update 2 Annual General Meeting 2 Regulatory Approval 1 Production Started 1 Price Movement Clarification 1 Other Announcement 1 Dividend 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

31 Jul 2026 17:20 IST BSE

Financial Results

Corona Remedies Q1 FY27 Results: Net Profit ₹60.1 Cr, Up 30.1% YoY

Corona Remedies Ltd reported revenue from operations of ₹422.4 Cr (+21.9% YoY) and net profit of ₹60.1 Cr (+30.1% YoY) for Q1 FY27.

Key figure: Net profit ₹60.1 Cr · +30.1% YoY

Open full results → Read the filing ↗

11 May 2026 18:52 IST NSE

Financial Results

Corona Remedies Q4 FY26 Results: Net Profit ₹45.3 Cr, Up 43.4% YoY

Corona Remedies Ltd reported revenue from operations of ₹353.1 Cr (+20.2% YoY) and net profit of ₹45.3 Cr (+43.4% YoY) for Q4 FY26.

Key figure: Net profit ₹45.3 Cr · +43.4% YoY

Open full results → Read the filing ↗

11 May 2026 18:33 IST NSE

Financial Results

Corona Remedies Financial Results

CORONA Remedies reported FY26 total standalone income of ₹1,413.83 Crore. The Board recommended a 100% final dividend of ₹10 per equity share.

Value: ₹1,414 Cr

Read the filing ↗